Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 2
1993 3
1994 1
1996 2
1997 3
1999 3
2000 4
2001 3
2002 3
2003 8
2004 9
2005 5
2006 6
2007 4
2008 9
2009 11
2010 11
2011 9
2012 3
2013 7
2014 7
2015 9
2016 14
2017 16
2018 16
2019 28
2020 26
2021 18
2022 25
2023 17
2024 12
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Results by year

Filters applied: . Clear all
Page 1
The Cerebrospinal Fluid in Multiple Sclerosis.
Deisenhammer F, Zetterberg H, Fitzner B, Zettl UK. Deisenhammer F, et al. Front Immunol. 2019 Apr 12;10:726. doi: 10.3389/fimmu.2019.00726. eCollection 2019. Front Immunol. 2019. PMID: 31031747 Free PMC article. Review.
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
Hegen H, Walde J, Berek K, Arrambide G, Gnanapavan S, Kaplan B, Khalil M, Saadeh R, Teunissen C, Tumani H, Villar LM, Willrich MAV, Zetterberg H, Deisenhammer F. Hegen H, et al. Among authors: deisenhammer f. Mult Scler. 2023 Feb;29(2):169-181. doi: 10.1177/13524585221134213. Epub 2022 Dec 1. Mult Scler. 2023. PMID: 36453167 Free PMC article. Review.
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).
Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, Enzinger C, Fertl E, Gass A, Gehring K, Gobbi C, Goebels N, Guger M, Haghikia A, Hartung HP, Heidenreich F, Hoffmann O, Kallmann B, Kleinschnitz C, Klotz L, Leussink VI, Leutmezer F, Limmroth V, Lünemann JD, Lutterotti A, Meuth SG, Meyding-Lamadé U, Platten M, Rieckmann P, Schmidt S, Tumani H, Weber F, Weber MS, Zettl UK, Ziemssen T, Zipp F; ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG). Wiendl H, et al. Among authors: deisenhammer f. Ther Adv Neurol Disord. 2021 Aug 18;14:17562864211039648. doi: 10.1177/17562864211039648. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34422112 Free PMC article. Review.
Preface.
Deisenhammer F, Teunissen CE, Tumani H. Deisenhammer F, et al. Handb Clin Neurol. 2017;146:ix. doi: 10.1016/B978-0-12-804279-3.09987-1. Handb Clin Neurol. 2017. PMID: 29110783 No abstract available.
Vascular diseases and bleedings.
Hegen H, Auer M, Deisenhammer F. Hegen H, et al. Among authors: deisenhammer f. Handb Clin Neurol. 2017;146:207-236. doi: 10.1016/B978-0-12-804279-3.00013-7. Handb Clin Neurol. 2017. PMID: 29110771 Review.
[Orthostatic tremor].
Willeit J, Deisenhammer F, Ransmayr G, Gerstenbrand F. Willeit J, et al. Among authors: deisenhammer f. Dtsch Med Wochenschr. 1991 Oct 4;116(40):1509-12. doi: 10.1055/s-2008-1063781. Dtsch Med Wochenschr. 1991. PMID: 1914921 German.
Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI Activity.
Bsteh G, Aicher ML, Walde JF, Krajnc N, Haider L, Traxler G, Gradl C, Salmen A, Riedl K, Poskaite P, Leyendecker P, Altmann P, Auer M, Berek K, Di Pauli F, Kornek B, Leutmezer F, Rommer PS, Zulehner G, Zrzavy T, Deisenhammer F, Chan A, Berger T, Hoepner R, Hammer H, Hegen H. Bsteh G, et al. Among authors: deisenhammer f. Neurology. 2024 Sep 24;103(6):e209752. doi: 10.1212/WNL.0000000000209752. Epub 2024 Aug 28. Neurology. 2024. PMID: 39197111
Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study.
Hegen H, Berek K, Cavalla P, Christiansen M, Emeršič A, Di Filippo M, Gaetani L, Hassler M, Leurs C, Milosavljevic D, van Pesch V, Petersen T, Presslauer S, Rosenstein I, Rot U, Schnabl C, Teunissen C, Vecchio D, Vercellino M, Deisenhammer F. Hegen H, et al. Among authors: deisenhammer f. Front Immunol. 2023 Dec 19;14:1327947. doi: 10.3389/fimmu.2023.1327947. eCollection 2023. Front Immunol. 2023. PMID: 38169789 Free PMC article.
Neurofilament ELISA validation.
Petzold A, Altintas A, Andreoni L, Bartos A, Berthele A, Blankenstein MA, Buee L, Castellazzi M, Cepok S, Comabella M, Constantinescu CS, Deisenhammer F, Deniz G, Erten G, Espiño M, Fainardi E, Franciotta D, Freedman MS, Giedraitis V, Gilhus NE, Giovannoni G, Glabinski A, Grieb P, Hartung HP, Hemmer B, Herukka SK, Hintzen R, Ingelsson M, Jackson S, Jacobsen S, Jafari N, Jalosinski M, Jarius S, Kapaki E, Kieseier BC, Koel-Simmelink MJ, Kornhuber J, Kuhle J, Kurzepa J, Lalive PH, Lannfelt L, Lehmensiek V, Lewczuk P, Livrea P, Marnetto F, Martino D, Menge T, Norgren N, Papuć E, Paraskevas GP, Pirttilä T, Rajda C, Rejdak K, Ricny J, Ripova D, Rosengren L, Ruggieri M, Schraen S, Shaw G, Sindic C, Siva A, Stigbrand T, Stonebridge I, Topcular B, Trojano M, Tumani H, Twaalfhoven HA, Vécsei L, Van Pesch V, Vanderstichele H, Vedeler C, Verbeek MM, Villar LM, Weissert R, Wildemann B, Yang C, Yao K, Teunissen CE. Petzold A, et al. Among authors: deisenhammer f. J Immunol Methods. 2010 Jan 31;352(1-2):23-31. doi: 10.1016/j.jim.2009.09.014. Epub 2009 Oct 24. J Immunol Methods. 2010. PMID: 19857497 Free article.
262 results